This review discusses the evidence concerning the effect of topical medications
and their preservatives on the ocular surface in glaucoma patients.
The role of topical anti-glaucoma medication remains critical in the
management
of chronic glaucoma worldwide but the beneficial effects of treatment are counterbalanced by the adverse effects of corneal and conjunctival toxicity.